Ticker Scorecard - IOVA Basics Company: Iovance Biotherapeutics, Inc. IPO Date: October 23, 2013 Sector: Healthcare Industry: Biotech Market Cap: $1.77B Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 3.09% Avg Daily Range (30 D): $0.17 | 2.58% Avg Daily Range (90 D): $0.22 | 2.55% Institutional Daily Volume Avg Daily Volume: 2.73M Avg Daily Volume (30 D): 7.57M Avg Daily Volume (90 D): 6.04M Trade Size Avg Trade Size (Sh.): 136 Avg Trade Size (Sh.) (30 D): 189 Avg Trade Size (Sh.) (90 D): 172 Institutional Trades Total Inst.Trades: 5,054 Avg Inst. Trade: $2.58M Avg Inst. Trade (30 D): $2.98M Avg Inst. Trade (90 D): $3.37M Avg Inst. Trade Volume: .2M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.2M Avg Closing Trade (30 D): $5.52M Avg Closing Trade (90 D): $4.93M Avg Closing Volume: 335.62K     News Jan 29, 2025 @ 1:30 PM Where Will Iovance Biotherapeutics Be in 5 Years? Source: Prosper Junior Bakiny Jan 27, 2025 @ 9:31 AM Meet the Growth Stock That Could Soar 280%, Accord... Source: Cory Renauer Jan 17, 2025 @ 10:00 PM Iovance Biotherapeutics Reports Inducement Grants ... Source: N/A Jan 9, 2025 @ 9:52 AM Immunotoxins Market Trends and Regional Business O... Source: Researchandmarkets.Com Dec 20, 2024 @ 10:00 PM Iovance Biotherapeutics Reports Inducement Grants ... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.48 $-.28 $-.34 Diluted EPS $-1.48 $-.28 $-.34 Revenue $ 90.86M $ 58.56M $ 31.11M Gross Profit $ 8.04M $ 18.73M $ -.26M Net Income / Loss $ -410M $ -83.54M $ -97.1M Operating Income / Loss $ -429.96M $ -89.07M $ -101.91M Cost of Revenue $ 82.82M $ 39.82M $ 31.37M Net Cash Flow $ -163.61M $ -64.57M $ 94.49M PE Ratio     Splits Sep 26, 2013:   100:1 Apr 06, 2010:   1:24